Silver Lake Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
1,364
+2
| +0.1% | +$2.03K | 0.5% | 55 |
|
|
2025
Q4 | $1.46M | Buy |
1,362
+2
| +0.1% | +$1.91K | 0.57% | 54 |
|
|
2025
Q3 | $1.04M | Sell |
1,360
-191
| -12% | -$142K | 0.41% | 59 |
|
|
2025
Q2 | $1.21M | Sell |
1,551
-49
| -3% | -$38.1K | 0.51% | 57 |
|
|
2025
Q1 | $1.32M | Buy |
1,600
+2
| +0.1% | +$1.66K | 0.58% | 56 |
|
|
2024
Q4 | $1.23M | Sell |
1,598
-39
| -2% | -$32.3K | 0.54% | 56 |
|
|
2024
Q3 | $1.45M | Sell |
1,637
-16
| -1% | -$14.4K | 0.59% | 55 |
|
|
2024
Q2 | $1.5M | Sell |
1,653
-28
| -2% | -$22.4K | 0.67% | 51 |
|
|
2024
Q1 | $1.31M | Buy |
+1,681
| New | +$1.2M | 0.58% | 52 |
|
|
2023
Q3 | – | Sell |
-1,698
| Closed | -$796K | – | 76 |
|
|
2023
Q2 | $796K | Buy |
1,698
+2
| +0.1% | +$839 | 0.43% | 56 |
|
|
2023
Q1 | $582K | Buy |
+1,696
| New | +$572K | 0.32% | 59 |
|
|
2022
Q4 | – | Sell |
-1,692
| Closed | -$547K | – | 76 |
|
|
2022
Q3 | $547K | Buy |
1,692
+2
| +0.1% | +$634 | 0.32% | 64 |
|
|
2022
Q2 | $548K | Buy |
1,690
+2
| +0.1% | +$600 | 0.3% | 64 |
|
|
2022
Q1 | $483K | Buy |
1,688
+2
| +0.1% | +$515 | 0.23% | 74 |
|
|
2021
Q4 | $466K | Buy |
1,686
+2
| +0.1% | +$507 | 0.22% | 81 |
|
|
2021
Q3 | $389K | Buy |
1,684
+3
| +0.2% | +$740 | 0.19% | 87 |
|
|
2021
Q2 | $430K | Buy |
1,681
+2
| +0.1% | +$402 | 0.21% | 79 |
|
|
2021
Q1 | $314K | Buy |
1,679
+3
| +0.2% | +$587 | 0.16% | 84 |
|
|
2020
Q4 | $283K | Buy |
1,676
+3
| +0.2% | +$448 | 0.15% | 82 |
|
|
2020
Q3 | $248K | Buy |
1,673
+3
| +0.2% | +$464 | 0.15% | 82 |
|
|
2020
Q2 | $274K | Buy |
1,670
+3
| +0.2% | +$460 | 0.18% | 74 |
|
|
2020
Q1 | $231K | Buy |
1,667
+3
| +0.2% | +$412 | 0.17% | 77 |
|
|
2019
Q4 | $219K | Buy |
+1,664
| New | +$193K | 0.13% | 79 |
|
|
2019
Q2 | – | Sell |
-1,654
| Closed | -$215K | – | 83 |
|
|
2019
Q1 | $215K | Sell |
1,654
-849
| -34% | -$103K | 0.15% | 81 |
|
|
2018
Q4 | $290K | Buy |
2,503
+5
| +0.2% | +$559 | 0.22% | 73 |
|
|
2018
Q3 | $268K | Buy |
2,498
+32
| +1% | +$3.2K | 0.16% | 83 |
|
|
2018
Q2 | $203K | Buy |
+2,466
| New | +$203K | 0.16% | 77 |
|
|
2018
Q1 | – | Sell |
-2,482
| Closed | -$210K | – | 85 |
|
|
2017
Q4 | $210K | Buy |
2,482
+5
| +0.2% | +$425 | 0.15% | 85 |
|
|
2017
Q3 | $212K | Buy |
2,477
+11
| +0.4% | +$902 | 0.16% | 81 |
|
|
2017
Q2 | $203K | Buy |
2,466
+9
| +0.4% | +$734 | 0.15% | 83 |
|
|
2017
Q1 | $207K | Sell |
2,457
-275
| -10% | -$22K | 0.16% | 80 |
|
|
2016
Q4 | $201K | Buy |
2,732
+10
| +0.4% | +$745 | 0.16% | 80 |
|
|
2016
Q3 | $218K | Buy |
2,722
+9
| +0.3% | +$720 | 0.16% | 78 |
|
|
2016
Q2 | $214K | Buy |
+2,713
| New | +$204K | 0.16% | 78 |
|
|
2016
Q1 | – | Sell |
-2,697
| Closed | -$227K | – | 68 |
|
|
2015
Q4 | $227K | Buy |
2,697
+9
| +0.3% | +$747 | 0.2% | 65 |
|
|
2015
Q3 | $225K | Buy |
2,688
+10
| +0.4% | +$844 | 0.2% | 68 |
|
|
2015
Q2 | $224K | Buy |
+2,678
| New | +$204K | 0.18% | 75 |
|
Other funds holding LLY
VCM
VPM
Silver Lake Advisory's LLY Position: Q1 2026 in Review
Silver Lake Advisory increased its Eli Lilly (LLY) stake by 0.15% in Q1 2026, buying an estimated $2.03K and bringing the position to 1,364 shares worth $1.25M. The position accounts for 0.5% of the portfolio, ranked #55.
Silver Lake Advisory first reported a position in LLY in Q2 2015 and has held it in 37 quarters since. The position peaked at $1.5M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Silver Lake Advisory held 1,364 shares of Eli Lilly worth $1.25M as of Q1 2026.
- Silver Lake Advisory bought 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
- Eli Lilly made up 0.5% of Silver Lake Advisory's portfolio in Q1 2026, its #55 holding.
- Silver Lake Advisory first reported a position in Eli Lilly in Q2 2015 and has held it in 37 quarters since.
- Silver Lake Advisory's Eli Lilly position peaked at $1.5M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Silver Lake Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.